SYN-Tech Chem & Pharm Co Ltd (1777) — Capital Reinvestment Ratio
SYN-Tech Chem & Pharm Co Ltd (1777) has a Capital Reinvestment Ratio of 0.08x as of December 2025, meaning it reinvests 0% of its operating cash flow (NT$256.05 Million) in capital expenditures (NT$21.16 Million). See 1777 equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
SYN-Tech Chem & Pharm Co Ltd Capital Reinvestment Ratio (2015–2025)
This chart tracks SYN-Tech Chem & Pharm Co Ltd's Capital Reinvestment Ratio across 11 annual periods. Check total reinvestment intensity of SYN-Tech Chem & Pharm Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for SYN-Tech Chem & Pharm Co Ltd (2015–2025)
Year-by-year Capital Reinvestment Ratio for SYN-Tech Chem & Pharm Co Ltd from 2015 to 2025. For live market cap and broader valuation context, see market value of SYN-Tech Chem & Pharm Co Ltd.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | NT$559.49 Million | NT$58.30 Million | ▼ -69.6% |
| 2024 | 0.34x | NT$622.61 Million | NT$213.75 Million | ▼ -79.4% |
| 2023 | 1.67x | NT$262.29 Million | NT$437.34 Million | ▲ +53.3% |
| 2022 | 1.09x | NT$438.81 Million | NT$477.40 Million | ▲ +34.2% |
| 2021 | 0.81x | NT$156.98 Million | NT$127.22 Million | ▲ +300.3% |
| 2020 | 0.20x | NT$319.21 Million | NT$64.62 Million | ▼ -26.9% |
| 2019 | 0.28x | NT$228.12 Million | NT$63.20 Million | ▼ -32.5% |
| 2018 | 0.41x | NT$188.49 Million | NT$77.33 Million | ▼ -91.5% |
| 2017 | 4.84x | NT$42.89 Million | NT$207.40 Million | ▲ +512.4% |
| 2016 | 0.79x | NT$235.26 Million | NT$185.73 Million | ▲ +55.8% |
| 2015 | 0.51x | NT$149.84 Million | NT$75.95 Million | — |